Health

  • April 27, 2026

    Attys, Advocates Call DOJ Pot Rule Historic Shift For Feds

    Legal strategies are evolving quickly in the wake of last week's "historic" rescheduling of state-legal medical cannabis, as a group of attorneys and advocates gathered Monday to evaluate the trade-offs of dispensaries now being able to register like pharmacies with the feds and the potential effect on industry investments and trade.

  • April 27, 2026

    IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client

    IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at least $180 million, according to a lawsuit filed in North Carolina Business Court.

  • April 27, 2026

    4 Firms Build Astorg's $1.1B Microbiology Biz Buy

    Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

  • April 27, 2026

    Ex-Federal Workers Seek Reinstatement In Md. Federal Court

    The Trump administration disguised ideologically motivated firings as routine layoffs, then pushed workers into a broken system to challenge their discharges, a group of laid-off federal workers alleged, asking a Maryland federal judge to deem the layoffs unconstitutional and reinstate the workers to their former positions.

  • April 27, 2026

    Cannabis Co. Can't Shift Atty AI Sanctions To Rival Company

    A Florida federal judge will not force a medical marijuana company to accept liability for sanctions incurred by its in-house counsel over the misuse of generative artificial intelligence, rejecting a rival company's arguments that the lawyer previously avoided monetary sanctions for filing errors and was likely to do so again.

  • April 27, 2026

    Convicted Pa. Dentist Says Feds Failed To Prove Fraud

    A Pennsylvania dentist convicted along with his brother for using their dental practice to defraud Medicare, install unapproved dental implants in patients, and falsify visas to recruit foreign workers has asked a federal judge for acquittal or a new trial, arguing the government failed to show he committed any crimes.

  • April 27, 2026

    Medical Group Says Secret Call Could Upend Estate's Verdict

    A Connecticut anesthesiology group has asked a state appeals court to reverse its portion of a $20 million wrongful death verdict, saying a lower court judge should have allowed into evidence a secret phone recording of a surgeon, used different verdict forms and blocked testimony from an allegedly unqualified witness.

  • April 27, 2026

    What To Watch As Justices Take On 'Skinny Label' Case

    The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called skinny label, a case with ramifications for the drug industry that could shape patent disputes more broadly and other legal areas. Here's what to watch for.

  • April 27, 2026

    4th Circ. Says Medicaid Fraud Convictions Lacked Evidence

    The government failed to prove the former owner of a mental health counseling company in Virginia willfully committed fraud by falsely billing Medicaid $200,000 for counseling services on two specific dates, a panel of the Fourth Circuit has found, overturning his convictions.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

  • April 27, 2026

    US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal

    Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation from one U.S. and one Indian law firm.

  • April 24, 2026

    Disability Groups Back Psilocybin Home Access In Ore.

    The Oregon Health Authority's refusal to allow home-based psilocybin services for terminally ill patients who cannot travel violates federal law, a coalition of disability rights groups have told an Oregon federal court in a brief in favor of broadening the state's psilocybin access program.

  • April 24, 2026

    Tenn. Abortion Ban Trial Taken Off Calendar Following Appeal

    A Tennessee state court has canceled a trial scheduled to begin Monday over a suit challenging the state's abortion ban and seeking clarification on when a physician can legally terminate a high-risk pregnancy.

  • April 24, 2026

    Ex-Medical Co. Employee Sues For Whistleblower Retaliation

    Luminis Health Inc. has been sued by a former employee alleging the Maryland-based healthcare group fired him for blowing the whistle on billing fraud and discriminated against him because of his race.

  • April 24, 2026

    Up Last At High Court: TPS, Geofence, Skinny Labels

    The U.S. Supreme Court will close out its oral argument portion of the 2025 October term by hearing a panoply of disputes over the constitutionality of geofence warrants, the existence of aiding and abetting torture claims, and the rescission of temporary protected status for hundreds of thousands of immigrants.

  • April 24, 2026

    Texas Justices Toss Trans Youth Probe Suit As Moot

    Texas officials were freed from court orders blocking them from launching probes on parents thought to have provided certain gender-affirming care to their children, with the state high court on Friday calling the underlying litigation moot after the state closed the investigations and the teenagers became adults.

  • April 24, 2026

    Natera Tells Justices CareDx Made Up Circ. Split In Petition

    Natera asked the U.S. Supreme Court to reject a petition from rival CareDx asking it to review a Third Circuit decision that erased a $45 million jury verdict stemming from CareDx's false advertising claims, saying Friday the circuit split that CareDx claims exists is "imagined."

  • April 24, 2026

    Atty In 'Maya' Case Isn't Owed $10M In Fees, Judge Told

    An attorney for Maya Kowalski, the subject of the Netflix documentary "Take Care of Maya," told a Florida judge Friday that her former lawyer has no right to $9.9 million in attorney fees because the fee agreement between them is unenforceable.

  • April 24, 2026

    Texas Panel Vacates $350K Unwanted Pregnancy Verdict

    A Texas appeals court has vacated a $350,000 verdict in favor of a woman suing her OB-GYN for failing to sterilize her, saying precedent from the state's supreme court holds that noneconomic damages from an unwanted pregnancy are unavailable, regardless of how that pregnancy ends.

  • April 24, 2026

    Cigna Plan Members Say HIPAA Notice Backs Privacy Claims

    A group of Cigna health plan participants who claimed the company failed to protect their private health information when it tracked their website activities told a Pennsylvania federal judge that the insurance giant should not be allowed to dodge new allegations that their HIPAA rights were violated.

  • April 24, 2026

    Blue Cross Licensee Seeks Exit From Claims Practices Suit

    A Blue Cross licensee told a Colorado federal judge that it has "no control" over Anthem Blue Cross and Blue Shield's provider network and therefore shouldn't have to face a treatment facilities operator's suit alleging it violated federal benefits and mental health parity laws.

  • April 24, 2026

    2 Plead Guilty Over Harvard Medical School Explosion

    Two Massachusetts men pled guilty Friday in Boston federal court to charges that they set off a commercial-grade firework inside a Harvard Medical School lab after a night of Halloween party-hopping last fall.

  • April 24, 2026

    Trump Admin Seeks Stay Of Vax Policy Suit Pending Appeal

    The Trump administration has asked a Massachusetts federal judge to press pause on a challenge to its new childhood vaccine schedule while it considers appealing the court's order blocking the changes, a request the plaintiffs called a delay tactic.

  • April 24, 2026

    Merck's $6.7B Terns Deal Clears Regulatory Hurdle

    Merck has cleared a key regulatory hurdle in its plan to acquire clinical stage oncology company Terns Pharmaceuticals Inc. for $6.7 billion, the pharmaceutical giant said Friday. 

  • April 24, 2026

    11th Circ. Panel Looks Split On Ga.'s Trans Prison Care Ban

    An Eleventh Circuit panel appeared divided Friday over whether to reverse a Georgia federal judge's order blocking the state from cutting off funding for transgender prisoners' hormone therapy, with one judge insisting that the state had de facto conceded the treatment was medically necessary.

Expert Analysis

  • Series

    Alpine Skiing Makes Me A Better Lawyer

    Author Photo

    Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.

  • Weighing The Practical Implications Of SC Kids' Privacy Law

    Author Photo

    South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.

  • FDA Guidance May Move Goalposts For Form 483 Responses

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.

  • 2 Strands Of Patent Law In High Court's 'Skinny Label' Case

    Author Photo

    Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction between two different strands of intellectual property law — analogizing a patent to either a property deed or a home, says Jonas McDavit at Spencer West.

  • Telehealth Suit May Redraw Rules For Physician Classification

    Author Photo

    A new class action in California federal court, Cioppettini v. Mochi Medical, alleging a telehealth company misclassified providers as independent contractors, suggests that traditional markers of physician independence may not apply to telehealth, say attorneys at Reed Smith.

  • Legal Theories In Social Media Verdicts Hold Clues On Impact

    Author Photo

    Although the two verdicts in cases in New Mexico and California involving Meta and Google are being lumped together, they rest on fundamentally different legal theories, and that distinction determines how their effects may be felt in other jurisdictions, says Mark Morgan at Day Pitney.

  • Senior Housing Demands A Distinct Dealmaking Playbook

    Author Photo

    An aging population and evolving state regulations underscore a critical reality that senior housing assets can undergo operational or compliance shifts during dealmaking, highlighting the need for unique contractual safeguards like expanded disclosures, anchored notice obligations, and targeted closing conditions and remedies, say attorneys at Goodwin.

  • Why MDLs Slow Down — And How To Speed Them Up

    Author Photo

    Multidistrict litigation has become central to mass tort practice, but as MDLs grow in size and complexity, so do delays and costs — so tools like the new federal rule governing MDLs, targeted use of special masters and strategically deployed Lone Pine orders are more essential than ever, say attorneys at Ice Miller.

  • A Check-Up On HHS' Push To Implement AI Infrastructure

    Author Photo

    The U.S. Department of Health and Human Services has made some headway in its efforts to implement artificial intelligence across its agencies, but will have to overcome a number of near-term tests in order to be successful, says Theodore Thompson at Stinson.

  • What A Court Doc Audit Reveals About Erroneous Filings

    Author Photo

    My audit of 1,522 court documents from last month found that over 95% contained at least one verifiable error, with fewer than 1% showing clear indicators of artificial intelligence use — highlighting above all else that lawyers may want to focus most on strengthening their review processes, says Elliott Ash at ETH Zurich.

  • Exploring When Fraud Asset Freezes Limit Right To Pick Atty

    Author Photo

    The defendant’s claim in the Seventh Circuit’s pending U.S. v. Shah case that the government restrained his assets until he couldn’t afford his chosen counsel presents a useful case study in how criminal forfeiture procedure interacts with U.S. Supreme Court rulings on Sixth Amendment rights and appealing complex fraud convictions, says Elisha Kobre at Sheppard.

  • Similar-Looking Designs May Not Always Prove Infringement

    Author Photo

    The Federal Circuit's recent decision in Range of Motion Products v. Armaid is a reminder that even a strikingly similar design might not be found to infringe upon a patented design once design features driven by functionality are filtered out from consideration, say attorneys at BCLP.

  • Series

    Mich. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    Michigan's financial services sector saw several significant developments in 2026's first quarter, including the state Department of Insurance and Financial Services' issuance of a bulletin on the use of artificial intelligence and the Michigan House's introduction of a bill based on the Model Money Transmission Modernization Act, say attorneys at Dykema.

  • The Road Ahead For Drug Development In The US

    Author Photo

    Against the backdrop of drug manufacturers potentially looking to move development efforts overseas, the U.S. Food and Drug Administration's latest guidance on new approach methodologies signals the FDA is likely to be receptive to industry innovation that makes U.S.-based drug development faster or less expensive, creating opportunities and compliance risks for tech companies, say attorneys at Morgan Lewis.

  • FDA's Crackdown On Drug Ads Conflicts With Precedent

    Author Photo

    Recent U.S. Food and Drug Administration warning letters to drug manufacturers targeting direct-to-consumer advertising raise significant constitutional concerns, and directly clash with prior FDA stances, say attorneys at Sidley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.